Drug Shortage Report for MYLAN-ATORVASTATIN
| Report ID | 11785 |
| Drug Identification Number | 02392968 |
| Brand name | MYLAN-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90BT, 500BT |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-10-16 |
| Actual start date | |
| Estimated end date | 2018-10-19 |
| Actual end date | 2018-10-15 |
| Shortage status | Avoided shortage |
| Updated date | 2018-10-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v51 | 2018-10-16 | French | Compare |
| v50 | 2018-10-16 | English | Compare |
| v49 | 2018-10-09 | French | Compare |
| v48 | 2018-10-09 | English | Compare |
| v47 | 2018-10-03 | French | Compare |
| v46 | 2018-10-03 | English | Compare |
| v45 | 2018-10-01 | French | Compare |
| v44 | 2018-10-01 | English | Compare |
| v43 | 2018-09-27 | English | Compare |
| v42 | 2018-09-24 | French | Compare |
| v41 | 2018-09-24 | English | Compare |
| v40 | 2018-09-20 | French | Compare |
| v39 | 2018-09-20 | English | Compare |
| v38 | 2018-09-17 | French | Compare |
| v37 | 2018-09-17 | English | Compare |
| v36 | 2018-09-17 | English | Compare |
| v35 | 2018-09-13 | French | Compare |
| v34 | 2018-09-13 | English | Compare |
| v33 | 2018-09-13 | French | Compare |
| v32 | 2018-09-13 | English | Compare |